Welcome to the our Aesthetic Medicine news roundup, 13 August 2021.
News Roundup
Sydney plastic surgeon awarded $450,000 over ‘tirade’ of online abuse
Sydney plastic surgeon, Dr Warwick Nettle, has been awarded $450,000 in damages for defamation after the Federal Court found he was the target of a tirade of online abuse by a woman on whom he decided not to operate.
Flu shots may protect against severe complications from COVID-19
A new study reveals the annual influenza vaccine may provide significant protection against some of the most serious complications from a coronavirus infection.
The motivation behind aesthetic medicine amidst the pandemic era
There have been immense changes to health practices, including dermatology and aesthetic medicine, in the last year due to the COVID-19 pandemic. In March 2020, when Australia shut its borders to keep the virus at bay, nonessential services were also closed until the virus was under control.
Botox Approved to Treat Spasticity in 8 New Arm, Hand Muscles
The U.S. Food and Drug Administration (FDA) has expanded the label for Botox (onabotulinumtoxinA) in adults for the treatment of upper limb spasticity — a common symptom of multiple sclerosis (MS) — to include eight more muscles.
Profhilo: What you need to know about this new Italian beauty treatment
You’ve tried Botox. You’ve given fillers a go. Vampire facials? Tick. Well, a new anti-ageing treatment, likened to an injectable moisturiser that plumps up the skin, is getting the cosmetic industry excited. The Italian treatment, Profhilo, is popular overseas, and since November it’s been available to Kiwis.
AbbVie raises annual profit forecast as Botox demand rebounds
Drugmaker AbbVie Inc raised its 2021 adjusted profit forecast on Friday, betting that a demand uptick for its Botox anti-wrinkle injection due to easing lockdowns will help overcome weak international sales for blockbuster drug Humira.
AMP
